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Abstract
The protein N-Myc downstream-regulated gene 1 (NDRG1) is implicated in the regulation of cell proliferation,
differentiation, and cellular stress response. NDRG1 is expressed in primary human trophoblasts, where it promotes
cell viability and resistance to hypoxic injury. The mechanism of action of NDRG1 remains unknown. To gain further
insight into the intracellular action of NDRG1, we analyzed the expression pattern and cellular localization of
endogenous NDRG1 and transfected Myc-tagged NDRG1 in human trophoblasts exposed to diverse injuries. In
standard conditions, NDRG1 was diffusely expressed in the cytoplasm at a low level. Hypoxia or the hypoxia mimetic
cobalt chloride, but not serum deprivation, ultraviolet (UV) light, or ionizing radiation, induced the expression of
NDRG1 in human trophoblasts and the redistribution of NDRG1 into the nucleus and cytoplasmic membranes
associated with the endoplasmic reticulum (ER) and microtubules. Mutation of the phosphopantetheine attachment
site (PPAS) within NDRG1 abrogated this pattern of redistribution. Our results shed new light on the impact of cell
injury on NDRG1 expression patterns, and suggest that the PPAS domain plays a key role in NDRG1’s subcellular
distribution.
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Introduction
NDRG1 (also called RTP, DRG1, CAP43, RIT42, TDD5,
NDR1, and PROXY1) is a 394-amino acid protein that is
implicated in cell differentiation, stress, and hormonal response
[1-8]. Notwithstanding the ubiquitous expression of NDRG1 in
most cell types and its upregulation in numerous types of
cancer, a definitive analysis of NDRG1’s function in vivo
pointed to a role limited to myelin sheath maintenance and
regeneration. Ndrg1 knockout mice exhibit peripheral
neuropathy, hind limb weakness, and leg muscle atrophy at
age 3 months [9,10]. The expression of NDRG1 in murine
Schwann cells is enhanced during regeneration after sciatic
nerve injury [11]. These findings are attributed to a stop codon
non-sense mutation (R148X) [12] or to an exon-9-skipping
mutation (IVS8-1G>A, S181-K198) [13] found in humans with
hereditary motor and sensory neuropathy-Lom (HMSNL, also
known as Charcot-Marie-Tooth type 4D disease). This disease
is characterized by Schwann cell demyelination and
concomitant early axonal impairment affecting both motor and
sense peripheral nerves, and resulting in a loss of limb muscle
function and touch sensation in adulthood [12,13]. . In addition,
NDRG1-null mice exhibit impaired mast cell differentiation and
degranulation [8].
Using cultured primary human trophoblasts (PHT), we
previously found that NDRG1 plays a pivotal role in the
response of human placental trophoblasts to hypoxia, a
common placental injury during pregnancy that is associated
with impaired fetal growth [14,15]. . We found that hypoxia
dramatically increases NDRG1 expression in PHT cells.
Moreover, using overexpression and knock down approaches,
we showed that NDRG1 enhances trophoblast differentiation
and diminishes hypoxia-induced apoptosis [16]. Consistent with
a role in placental adaptation to injury, enhanced expression of
NDRG1 is associated with preeclampsia and fetal growth
restriction [17].
Diverse chemical and cellular signals stimulate the
expression of NDRG1, including reducing agents such as
tunicamycin [18], metals (cobalt, nickel, calcium, and iron
chelators) [19,20], nitric oxide [21], vitamin D [22], vitamin C
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[23], retinoids [7], androgens and estrogens [24-27], and DNA-
damaging compounds (actinomycin D, doxorubicin,
geldanamycin) [28-30].
While vital to cell function, the mechanism of action of
NDRG1 remains unknown. NDRG1 is a member of the Ndr
family of proteins [31]. All four members of this family harbor a
conserved α/β hydrolase fold, yet lack its catalytic motif,
rendering Ndr members devoid of hydrolase activity [32].
Moreover, the subcellular localization of NDRG1 is not uniform
across cell types. NDRG1 can be found in the cytoplasmic
membrane, desmosome and adherent junctions, mitochondria,
vacuoles, intermediate and microfilament bundles, and cell
nuclei and nucleoli [2,33-37].
To further our understanding of NDRG1’s function we
investigated the impact of diverse cellular insults on the
expression and subcellular distribution of NDRG1 in PHT cells
and trophoblast lines. Unlike with hypoxia, we found that
several other cellular insults had an insignificant effect on
NDRG1 expression. Moreover, hypoxia caused a marked
redistribution in NDRG1’s subcellular expression pattern, and
this effect was dependent upon an intact phosphopantetheine
attachment site (PPAS) motif within the α/β hydrolase fold of
NDRG1.
Materials and Methods
Cell lines and culture
BeWo, JEG-3, CHO, and NIH3T3 lines were purchased from
ATCC (Manassas, VA) and cultured as we previously detailed
[38-41]. We also previously characterized and detailed the
culture conditions of the uterine myocytes cell line SHM
[42,43]. PHT cells were purified from term human placentas
obtained by the Obstetrical Specimen Procurement Unit from
women after a healthy pregnancy, labor, and delivery at
Magee-Womens Hospital of the University of Pittsburgh
Medical Center. The placental tissue samples were collected
under an approved exempt protocol by the Institutional Review
Board of the University of Pittsburgh. Patients provided written
consent for the use of de-identified, discarded tissues for
research upon admittance to the Hospital. Cells were isolated
using the trypsin-deoxyribonuclease-dispase/Percoll method as
described by Kliman et al. [44], with previously published
modifications [45]. PHT culture density was 350,000 cells/cm2.
Cells were maintained in DMEM (Sigma-Aldrich Corp., St.
Louis, MO) supplemented with 10% FBS (HyClone, Logan, UT)
and antibiotics. The cells were maintained in standard
conditions (5% CO2 and 95% atmosphere, 37°C) before being
exposed to serum-free starvation, CoCl2 (50-200 µM), or
hypoxia (<1% O2) as previously described [39].
UV light irradiation of cells was carried out using a UV
Crosslinker XL-1000 equipped with 254-nm tubes (Spectronics
Corporation, Westbury, NY) at the energy of 6 mJ/cm2. For
exposure to ionizing irradiation, PHT cells were irradiated using
a Varian CLINAC 600C (Varian Medical Systems, Palo Alto,
CA) with a 6-MV photon beam and dose rate of 250 cGy/min.
Maximum radiation depth was 1.5 cm.
To determine protein decay, cells were exposed to the
protein synthesis inhibitor cycloheximide (10 µg/ml, Sigma, St.
Louis, MO) for 3, 6, 12, and 24 h at 48 h after transfection with
plasmids expressing either myc-tagged NDRG1 wild type or
myc-tagged PPAS deleted mutants. Cellular proteins were
extracted, measured and processed for western blot as
described below.
Plasmid construction and transfection
A DNA vector encoding human NDRG1 was provided by Dr.
Toshiyuki Miyata (National Cerebral and Cardiovascular
Center, Japan). To generate plasmid constructs expressing
Myc-tagged wild type or mutated NDRG1, the corresponding
cDNA fragments were PCR-amplified and inserted into the
NheI/BamHI site in pcDNA3.1/MycHisA(-) (Invitrogen,
Carlsbad, CA). All mutant clones were confirmed by restriction
digestion and DNA sequencing. Cells were transfected with 7.5
mM polyethylenimine as previously described [39].
Isolation of RNA and quantitative real-time PCR
Total RNA extraction, RNA quality assessment, and reverse
transcription were performed as we previously described [46].
Synthesized cDNA was diluted 1:5 in DNase- and RNase-free
H2O (Invitrogen), and 3 µl of diluted cDNA per 10 µl of reaction
mixture in a 384-well plate were used in duplicates of each
sample for RT-qPCR, carried out in Geneamp 7900 using
SYBR Green PCR master mix (Applied Biosystems, Forster
City, CA). PCR primers (Integrated DNA Technologies,
Coralville, Iowa) were validated using Primer Bank (Boston,
MA). Human YWHAZ served as an internal control.
Amplification specificity was routinely confirmed by dissociation
curves. The results were calculated by the ΔΔCt method [47] to
determine the relative gene expression.
Nucleus fractionation and Western blot analysis
The cell monolayer was washed, scraped in PBS, and
centrifuged at 2,000 g for 5 min. The pellet was resuspended
x5 v/v with buffer A (10 mM HEPES, 1.5 mM MgCl2, 10 mM
KCl, 0.5 mM dithiothreitol (DTT) containing the protease
inhibitors (1 mM PMSF, 10 µM leupeptin, 0.1 µM aprotinin, and
1 µM Pepstatin A) incubated on ice for 10 min, then centrifuged
at 12,000 g for 15 sec at 4°C. The cytosolic supernatant was
collected separately, and the nuclei-containing pellet was
resuspended x3 v/v of buffer C (20 mM HEPES, 1.5 mM MgCl2,
420 mM NaCl, 0.2 mM EDTA, 0.5 mM DTT) containing
protease inhibitors, as above, and incubated on ice for 1 h,
followed by a vigorous vortex for 30 sec, centrifugation at
12,000 g for 2 min at 4°C, and collection of the nuclear extract-
containing supernatant. Total cellular proteins were extracted
by incubation of the cells in 50 mM Tris-buffered saline (TBS)
containing 1% TX100, pH 7.4, on ice for 15 min. Cell debris
was removed by centrifugation at 12,000 g for 15 min.
Total protein concentration was measured with a BCA
protein assay kit (Thermo Scientific, Waltham, MA), using a
microplate reader (VersaMax, Molecular Devices, Sunnyvale,
CA). Extracted proteins from whole cell lysate or from
subcellular compartments were separated by SDS-PAGE
electrophoresis in 10% acrylamide/Bis gel (Bio-Rad, Hercules,
CA) and then transferred to polyvinylidene difluoride
membranes (Bio-Rad) at 25 V overnight. After blocking with
NDRG1 Expression in Trophoblasts
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50mM Tris-buffered saline with 0.1% Tween-20 (TBST)
containing 5% non-fat milk, the membranes were incubated
overnight with rabbit polyclonal anti-NDRG1 antibody (final
concentration 0.5 µg/ml, Invitrogen) or mouse monoclonal anti-
Myc antibody (1 µg/ml, Applied Biological Materials, Richmond,
BC) at 4°C. HIF-1α was detected using a mouse monoclonal
anti HIF-1α antibody (2 µg/ml, BD Biosciences, San Jose, CA).
Tubulin was detected using mouse anti-tubulin monoclonal
antibodies (1 µg/ml, Calbiochem, San Diego, CA). After
washing with TBST, the membranes were incubated with
horseradish peroxidase-conjugated goat anti-rabbit or goat
anti-mouse immunoglobulin G (0.15 µg/ml, Jackson
ImmunoResearch, West Grove, PA) for 2 h at room
temperature. Chemiluminescent signal was detected by
enhanced SuperSignal West Dura (Thermo Scientific) for
endogenous low level NDRG1 in cells cultured standard
conditions, or by SuperSignal West Pico for all other
conditions, using UVP Biospectrum 310 (UVP, Upland, CA).
Immunofluorescence staining
Cells were plated on cover glass in a 12-well plate as
described earlier, then fixed with 4% paraformaldehyde for 15
min, except for desmosome staining, for which the cells were
fixed with ice-cold methanol at -20°C for 20 min. After rinsing
with PBS, the cells were permeabilized and blocked with 0.1%
Triton X-100 in 50 mM Tris-HCl (pH 7.4) containing 150 mM
NaCl, 0.2 mg/mL NaN3, and 1 mg/ml BSA at room temperature
for 1 h. The cells were stained with rabbit polyclonal anti-
NDRG1 antibody (1 µg/ml) or mouse monoclonal anti–Myc tag
antibody (1 µg/ml, Applied Biological Materials) for 4 h at room
temperature. Cytoplasm membranes and desmosomes were
stained by rabbit monoclonal anti-E-cadherin antibody (0.25
µg/ml, Cell Signaling, Danvers, MA) and mouse monoclonal
anti-desmosome antibody (20 µg/ml, Sigma), respectively.
Chicken polyclonal anti-calreticulin (0.5 µg/ml, Abcam,
Cambridge, MA) and mouse anti-tubulin monoclonal antibodies
(0.25 µg/ml, Calbiochem) were used to stain ER and
microtubules. Peroxisomes were stained with rabbit polyclonal
PMP70 antibody (2 µg/ml, Abcam). After five washes with PBS,
primary antibodies were detected by 2 h incubation with the
corresponding fluorophore-conjugated secondary antibodies
(Alexa Fluor 488 or Alex Fluor 555). Actin filaments were
stained with FITC-phalloidin (50 nM) at room temperature for
20 min. Nuclei were stained with Hoechst 33342 (5 µg/ml) or
SYTOX Green (5 µM) for 5 min at room temperature, after
incubation with the secondary antibody. Mitochondria and
lysosomes were traced in live cells by incubation with
MitoTracker Red (100 nM) and LysoTracker Red (50 nM),
respectively, at 37°C for 30 min immediately before fixation. All
antibodies and fluorescent dyes were purchased from
Invitrogen unless otherwise stated. Images were captured
using a 60X lens plus 1-2X digital zoom using the Nikon
fluorescent microscope Eclipse Ti, equipped with Nikon’s A1
laser confocal system, and analyzed by NIS-Elements (Nikon
Instruments, Melville, NY).
Statistics
All experiments were repeated at least three times. Data are
presented as means ± S.D, where relevant. Statistical analysis
was performed using Student’s t-test based on log2
transformed fold change of mRNA expression. A p-value < 0.05
was considered significant.
Results
Hypoxia and CoCl2, but not non-hypoxic insults,
enhance NDRG1 expression in PHT cells
We previously showed that NDRG1 is expressed in human
placental tissue as well as in cultured term PHT cells [16,48].
Taking advantage of their wide use in trophoblast biology as
well as their accessibility to molecular manipulations, we used
trophoblast lines, alongside PHT cells, to assess the impact of
diverse cellular injuries on NDRG1 expression. We initially
determined that the expression of NDRG1 protein in the
trophoblast cell lines JEG-3, BeWo, and HTR-8/SVneo was
markedly higher than other non-placental cell types, such as
the myometrial line SHM, the ovarian line CHO, and NIH3T3
fibroblasts (Figure 1A). Hypoxia, as well as the hypoxia mimetic
CoCl2, stimulated NDRG1 expression in JEG-3 cells (Figure
1B-C) in a manner similar to that found when using PHT cells
[16].
To assess the influence of non-hypoxic cellular stress on
NDRG1 expression, we cultured BeWo cells in the presence or
absence of serum, and found that this had an insignificant
effect on NDRG1 expression (Figure 2A). Although UV
irradiation causes cell damage [49] (data not shown), we
observed no effect of UV irradiation on NDRG1 protein levels in
JEG-3 cells (Figure 2B) or in BeWo or HTR-8/SVneo cells
(data not shown). These results were confirmed using
immunofluorescent staining in JEG-3 cells (Figure 2C).
Whereas ionizing irradiation promotes trophoblast cell death
(manuscript in preparation), it had no effect on NDRG1 mRNA
or protein expression (Figure 2D). Similarly, there was no effect
on mRNA expression of other NDRG family members in PHT
cells (Figure 2D). Together, these data indicate that hypoxia,
but not other tested cellular stressors, enhances trophoblastic
NDRG1 expression.
Hypoxia causes subcellular redistribution of NDRG1
expression
To test whether hypoxia impacts the subcellular localization
of NDRG1, we cultured PHT cells under hypoxia for 24–72 h.
Whereas, under standard conditions, NDRG1 was diffusely
expressed in the cytoplasm and nucleus, hypoxia caused the
redistribution of NDRG1 to the cell membrane and nucleus of
PHT cells while sparing the nucleoli (Figure 3A). We observed
a similar effect using JEG-3 cells exposed to CoCl2 (Figure 3B),
and this finding was corroborated by cell fractionation and
Western immunoblotting (Figure 3C). Overexpression of a Myc-
tagged NDRG1 in CoCl2-exposed JEG-3 (Figure 3D) or
hypoxic BeWo cells (Figure 3E) confirmed these results,
showing a clear transition of NDRG1 from diffuse cytoplasmic
to nuclear and membrane localization. As shown in Figure 4,
hypoxia also enhanced NDRG1 expression at cytoplasmic
NDRG1 Expression in Trophoblasts
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membranes, where NDRG1 partly co-localized with
desmosomes (Figure 4A-D) and with E-cadherin-positive
membranes (Figure 4E-H), calreticulin-positive ER, (Figure 4I-
L), and cytoplasmic and perinuclear tubulin (Figure 4M-P). In
contrast, we found no evidence for localization of NDRG1 to
trophoblastic mitochondria, lysosomes, Golgi, peroxisomes, or
microfilaments (Figure S1).
PPAS motif and the cap-like domain within the α/β
hydrolase fold of NDRG1 are essential for protein
localization and stability
The conserved α/β hydrolase fold (Figure 5A) in Ndr family
members lacks a hydrolytic motif, rendering the protein devoid
of hydrolase activity [32,50,51]. As NDRG1 intensely localizes
to the nucleus upon exposure to hypoxia, we sought to identify
domains within NDRG1 that direct this subcellular
redistribution. In silico analysis (Network Protein Sequence
Analysis, Lyon, France) pointed to a potential nuclear
localization motif, helix-turn-helix (HTH) [52-54], at the N-
terminal of NDRG1.
Other sequences within NDRG1 that are not conserved in
other Ndr members include a unique three repeats (3xR) of 10-
amino acids at the protein’s C-terminal, which is known to bind
nickel [55], and the PPAS [56], located within the α/β hydrolase
fold at residues 128-143. In acyl carrier proteins (ACP) of multi-
enzyme complexes, such as fatty acid synthase, the PPAS
sequence provides an attachment site to a prosthetic group
Figure 1.  NDRG1 expression in trophoblast cell lines in response to hypoxia or CoCl2.  NDRG1 (upper panels) and tubulin
(loading control, lower panels) were detected using Western immunoblot. (A) NDRG1 expression in trophoblasts and trophoblast-
derived choriocarcinoma cell lines, as well as in other cell types under standard conditions. (B) NDRG1 expression in JEG-3 cells
cultured in standard conditions, 24 h of hypoxia (<1% O2) or the hypoxia mimetic CoCl2 (200 µM). The expression of HIF-1α (middle
panel) confirmed the effect of CoCl2 or hypoxia. (C) A time course and concentration-dependent stimulation of NDRG1 expression in
JEG-3 cells exposed to the hypoxia mimetic agent CoCl2. Data are representative of at least three independent experiments.
doi: 10.1371/journal.pone.0075473.g001
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that serves as a “swing arm” for easy access to activated fatty
acid substrate [57]. Our homology analysis also identified the
amino acid sequence A169-R235, which spans the region of
cap-like domain, a subdomain within the α/β hydrolase fold,
recently identified in the crystal structure of NDRG2.
The role of PPAS sequence and other domains within
NDRG1 is currently unknown. Using mutagenesis and
Figure 2.  The impact of non-hypoxic cell injury on NDRG1 expression in trophoblast lines.  (A) BeWo cells were incubated
for either 24 or 48 h in standard, serum-containing medium or in serum-free medium. NDRG1 was detected by Western immunoblot
(upper panel), and tubulin (lower panel) used for loading control. (B) JEG-3 cells were exposed to UV irradiation at the energy
dosage indicated, and harvested after 6 or 24 h after the brief (1-3 seconds) pulse of UV irradiation. Analysis was performed as
described in panel A. (C) Immunofluorescent staining of NDRG1 in JEG-3 cells 24 h after exposure to CoCl2 (200 µM), serum-free
medium, or UV irradiation (6 mJ/cm2). Panels are NDRG1 alone, or channel merge of NDRG1 (green) and Hoechst 33342 (blue),
used for nuclear staining. Bar = 20 µm(D) The expression of NDRG members in PHT cells 24 h after exposure to ionizing radiation
at the energy dose shown. Left panel shows RT-qPCR analysis, performed as described in Materials and Methods. None of the
differences were significant. Right panel depicts NDRG1 expression, detected as in panel A, in cells exposed to ionizing radiation at
the energy dosage shown. Analysis was performed as described in panel A. Data are representative of at least three independent
experiments.
doi: 10.1371/journal.pone.0075473.g002
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Figure 3.  The sub-cellular localization of NDRG1 in response to hypoxic injury.   Wild type or myc-tagged NDRG1, as well as
cell nuclei, were detected as described in Materials and Methods. (A) The impact of hypoxia on NDRG1 expression level and
localization in PHT cells exposed to hypoxia at the time period indicated. NDRG1 (green) is shown in the left panels, and a merged
channel of NDRG1 and nuclei (blue) is shown in the right panels. (B) JEG-3 cells were exposed to CoCl2 (200 µM) for 24 h, and
data analyzed as in (A). (C) A Western immunoblot of NDRG1 expression in the cytoplasmic (upper panel) or nuclear (lower panel)
fraction of JEG-3 cells cultured in standard or hypoxic conditions for the period of time indicated. Tubulin and lamin A/C were used
as markers of the cytoplasm and nucleus, respectively. (D) The impact of CoCl2 (200 µM for 24 h) on the localization of myc-tagged
NDRG1 in JEG-3 cells. Myc-tagged NDRG1 (red), E-cadherin (green), and nuclei (blue) are shown. (E) The impact of hypoxia (24 h,
<1% O2) on the localization of myc-tagged NDRG1 in BeWo cells. Myc-tagged NDRG1 (red) and nuclei (green) are shown. Data are
representative of at least three independent experiments. Bar = 20 µm in all panels.
doi: 10.1371/journal.pone.0075473.g003
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immunofluorescence, we found that expression of Myc-tagged
deletion mutants of the HTH and 3xR domains, as well as N-
and C- termini (Figure 5A), had no effect on protein localization
in hypoxic JEG-3 cells (Figure S2). In contrast, deletion of the
entire PPAS domain (residues 128–143) or partial PPAS
deletions, PPAS1 (residues 128–133) or PPAS2 (residues
133–143), abrogated nuclear localization of NDRG1 (Figure
5B, and data not shown). A selective deletion of the cap-like
domain (residues 169-235), which is also located within the α/β
hydrolase, had no effect on the nuclear localization of NDRG1
(Figure 5B). Notably PPAS deletion resulted in reduced protein
stability and a faster decay when compared to wild type
NDRG1 (Figure S3), which was restored by the proteasome
inhibitor MG-132 (Figure 5C, lower panel). However, the
restored protein failed to properly localize to the nucleus or
membrane-associated structures (Figure 5D).
Discussion
While NDRG1 is clearly germane to cellular stress response,
cancer, and the function of peripheral neurons, the expression
pattern and mechanism of action of NDRG1 remain largely
unknown. Building upon our previous data on the expression
and anti-apoptotic function of NDRG1 in trophoblasts exposed
to hypoxia [16,17,48], we showed that the expression of
NDRG1 is not upregulated by any cell stressor, but is
selectively enhanced by hypoxia or hypoxia mimetic chemicals.
Cell stress induced by serum deprivation or UV or ionizing
radiation had no effect on the expression of NDRG1.
Figure 4.  The expression of NDRG1 in cytoplasmic membranes or membrane-associated structures in hypoxic (24 h)
trophoblastic lines.  The nuclei (blue), in all panels, were detected using Hoechst 33342 and each organelle was detected using a
specific antibody as described in Materials and Methods. (A-D) NDRG1 (green) co-localizes with desmosomes (red) in JEG-3 cells.
(E-H) Myc-tagged NDRG1 (red) co-localizes with E-Cadherin (green) in BeWo cells. (I-L) Myc-tagged NDRG1 (green) co-localizes
with calreticulin (red) in BeWo cells. (M-P) Myc-tagged NDRG1 (green) co-localizes with tubulin (red) in BeWo cells. Arrow points to
perinuclear NDRG1 and tubulin signals. Arrowheads point to peripheral microtubules. Data are representative of at least three
independent experiments. Bar = 20 µm in panels A-H, and Bar = 10 µm in panels I-P.
doi: 10.1371/journal.pone.0075473.g004
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Figure 5.  The expression and nuclear localization of NDRG1 deletion mutants.  (A) Schematic representation of human
NDRG1 protein structure, depicting protein domains, including those mutated in NDRG1-related human diseases, as well as
NDRG1 deletion mutants generated in this study. (B) The subcellular localization of PPAS-deleted NDRG1 mutants in BeWo cells,
cultured in hypoxia (24 h, <1% O2). Myc-tagged NDRG1 wild type and ΔCAP but not ΔPPAS (red, upper panels) were co-localized
with nuclei (SYTOX Green, lower panels). Bar = 20 µm. (C) Upper panel: The expression of myc-tagged NDRG1 wild type or
mutants (mRNA, upper gel; protein, lower gel) in BeWo cells. Lower panels: the effect of the proteasome inhibitor MG-132 (5 µM, 16
h) on the expression of myc-tagged NDRG1 mutant in PPAS domain in BeWo cells, detected using Western immunoblot. (D) The
effect of the proteasome inhibitor MG-132 (5 µM, 16 h) on the subcellular localization of transfected mutant PPAS domain of
NDRG1 (red) in hypoxic BeWo cells. Bar = 10 µm. Data are representative of at least three independent experiments.
doi: 10.1371/journal.pone.0075473.g005
NDRG1 Expression in Trophoblasts
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Interestingly, a very prolonged cell culture (7–19 days) without
passage, or with several days of cell confluence (not shown),
also increased NDRG1 expression as previously reported [23],
suggesting that this effect might represent local hypoxia and
not nutrient deprivation.
Consistent with its pleiotropic function, NDRG1 has been
localized to diverse cellular organelles in different cell types—
including the cytoplasm, nucleus, membranes, endosomes,
mitochondria, and cytoskeleton [2,33-37]. However, no nuclear
localization signal or other membrane anchor motifs have been
identified within the protein. By detecting the expression pattern
of endogenous or Myc-tagged NDRG1, we found that hypoxia
not only upregulated, but also redistributed, trophoblastic
NDRG1 to the nucleus as well as to the cytoplasmic
membrane. While we identified an HTH motif near NDRG1’s N-
terminus, it was unnecessary for nuclear localization.
In contrast, mutation of the PPAS domain abrogated the
nuclear redistribution of NDRG1 in hypoxic trophoblasts. The
low expression level, perinuclear aggregation, decay, and
restoration of cellular levels by MG-132 suggest that PPAS
deletion destabilizes NDRG1, shuttling it to proteosomal
pathways for degradation. We also noted that the restored
NDRG1-ΔPPAS by MG-132 was not properly redistributed as
wild type NDRG1 in hypoxic cells. While these data do not
prove that the PPAS domain serves as NDRG1’s nuclear
localization signal, it is likely that NDRG1-ΔPPAS is disabled
secondary to protein misfolding or other structural
deformations.
The recently published crystal structure of both human and
mouse NDRG2 confirmed the predicted existence of a α/β-
hydrolase fold in the Ndr family proteins. This fold consists of
two subdomains: a large, canonical α/β-hydrolase domain and
a small, cap-like domain. Other than forming a part of the
pocket for substrate binding in α/β-hydrolases, the cap-like
domain stands out from the main body of α/β-hydrolases,
exhibiting multiple surface hydrophobic residues that may
contribute to its molecular interactions [51]. The exon-9
skipping mutation of NDRG1, which leads to HSMNL disease,
results in amino acid loss from S181-K198 in the cap-like
domain, thus highlighting the functional importance of this
domain. Our data suggest that the cap-like domain is not
necessary for the nuclear localization of NDRG1 in hypoxic
trophoblasts.
The function of NDRG1 in the nucleus of hypoxic cells
remains unknown. Our data suggest that NDRG1 functions in
the nucleus and cytoplasmic membranes during hypoxic stress.
Interestingly, a limited number of proteins have been shown to
be targets of NDRG1, including proteins associated with tumor
growth and metastasis, such as Thtpa, cathepsin C, ATF3 [58],
p53 [16,59], E-cadherin [60], the molecular chaperons Hsc70
[61] and Hsp90 [29], and the lipid-related proteins ApoAI and
ApoAII [62].
In addition to nuclear translocation, hypoxia also
redistributed NDRG1 to the cell membrane and cytoplasmic
membranous network closely associated with the ER and
microtubules. This suggests an adaptive role for NDRG1 in the
biosynthesis and transport of lipids, proteins, and
carbohydrates, which are critical functions of placental
trophoblasts in supporting the developing embryo. The fact that
the PPAS domain is found in ACP proteins of multi-enzyme
complexes such as fatty acid synthase [63], together with the
observation that NDRG1 binds ApoAI and ApoAII [62], argues
that there is a role for NDRG1 in promoting trophoblastic lipid
biosynthesis and transport during cell stress.
Supporting Information
Figure S1.  NDRG1 does not co-localize with several sub-
cellular organelles in trophoblastic cells under either
standard or hypoxic conditions. Parental cells or myc-
tagged NDRG1 transfectants at 48 h after transfection were
incubated in either standard conditions or hypoxia for 24 h. The
nuclei (blue) in all panels were detected using Hoechst 33342.
Organelle specific antibodies or fluorescent dyes were used to
locate subcellular organelles as described in Materials and
Methods. (A) Endogenous NDRG1 (green) does not co-localize
with mitochondria in JEG-3. (B-C) Myc-tagged NDRG1 (green)
does not co-localize with lysosomes (B, red) or Golgi (C, red) in
BeWo cells. (D-E) Myc-tagged NDRG1 (red) does not co-
localize with peroxisome (D, green) or microfilaments (E,
green) in BeWo cells. Data are representative of at least three
independent experiments. Bar = 20 µm in all panels.
(TIF)
Figure S2.  The cellular localization of NDRG1 is not
affected by N- or C- terminal deleted NDRG1 mutants
under hypoxic conditions. JEG-3 cells were transfected with
myc-tagged NDRG1 wild type or deletion mutants at the N- or
C- terminal as depicted in Figure 5A. At 48 h after transfection
the cells were exposed to CoCl2 (200 µM) or vehicle control for
24 h. Myc-tagged NDRG1 (red), E-cadherin (green), and nuclei
(blue) were stained as described in Materials and Methods.
Data are representative of at least three independent
experiments. Bar = 20 µm in all panels.
(TIF)
Figure S3.  Time dependent decay of NDRG1 wild type and
PPAS-deleted mutants after inhibition of protein synthesis.
293T cells were transfected with myc-tagged wild type NDRG1
or PPAS-deleted mutants. 48 h after transfection the cells were
exposed to cycloheximide (10 µg/ml) for the time period
indicated. NDRG1 protein levels (upper panels) after inhibition
of protein synthesis were analyzed by western blot as
described in Materials and Methods, with actin (lower panels)
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